AGPI - Lipides et signalisation cellulaire
AGPI - Lipides et signalisation cellulaire
AGPI - Lipides et signalisation cellulaire
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Système immunitaire & Hypertension :<br />
eff<strong>et</strong>s d’<strong>AGPI</strong> n-3<br />
PUFA/EPAX di<strong>et</strong>ary treatment diminishes blood pressure in SHR<br />
SHR control, 251 ± 16 mm Hg vs. SHR PUFA/EPAX, 209 ± 2 mm Hg<br />
WKY control, 161 ± 16 mm Hg vs. WKY PUFA/EPAX, 178 ± 7 mm Hg)